Treatment from birth of nonketotic hyperglycinemia due to a novel <i>GLDC</i> mutation

Abstract

Prospective treatment with this regimen can favorably modify the early neonatal course of severe NKH but does not prevent the poor long-term outcome, suggesting glycine-induced prenatal injury and/or ongoing postnatal damage.